CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$1.19 USD
+0.04 (3.48%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $1.20 +0.01 (0.84%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.12 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | -14.29% |
ABR | 1.86 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.20 |
Next Year | -0.56 |
EPS (TTM) | 0.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 18.92M | 15.72M | 103.85M | 84.08M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 25.10M | 25.00M | 119.80M | 101.50M |
Low Estimate | 12.00M | 6.10M | 84.70M | 50.00M |
Year ago Sales | 26.38M | 26.61M | 101.21M | 103.85M |
Year over Year Growth Est. | -28.28% | -40.92% | 2.60% | -19.04% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.12 | -0.11 | -0.20 | -0.56 |
# of Estimates | 5 | 5 | 5 | 4 |
Most Recent Consensus | -0.09 | -0.11 | -0.11 | -0.50 |
High Estimate | 0.09 | 0.23 | 0.23 | -0.46 |
Low Estimate | -0.24 | -0.31 | -0.49 | -0.76 |
Year ago EPS | 0.04 | 0.01 | -0.01 | -0.20 |
Year over Year Growth Est. | -400.00% | -1,200.00% | -1,900.00% | -181.25% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 5 | 4 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.12 | -0.11 | -0.20 | -0.56 |
7 Days Ago | -0.12 | -0.11 | -0.20 | -0.56 |
30 Days Ago | -0.12 | -0.11 | -0.20 | -0.56 |
60 Days Ago | -0.08 | -0.12 | -0.14 | -0.49 |
90 Days Ago | -0.08 | -0.12 | -0.14 | -0.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.12 | -0.11 | -0.20 | -0.56 |
Zacks Consensus Estimate | -0.12 | -0.11 | -0.20 | -0.56 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | 0.17 | 0.01 | 0.04 | NA |
Estimate | -0.07 | -0.06 | 0.02 | -0.17 | NA |
Difference | -0.01 | 0.23 | -0.01 | 0.21 | 0.11 |
Surprise | -14.29% | 383.33% | -50.00% | 123.53% | 110.64% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more